Patient Association: International Neuroendocrine Cancer Alliance (European Union): Difference between revisions
From Beacon
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
'''Access to information:''' [https://incalliance.org/ Click here to access]. | '''Access to information:''' [https://incalliance.org/ Click here to access]. | ||
{{Esophagus}} | |||
{{Stomach}} | |||
{{Small intestine}} | |||
{{Large intestine}} | |||
{{Rectum}} | |||
{{Anus}} | |||
{{Liver}} | |||
{{Gallbladder}} | |||
{{Bile ducts}} | |||
{{Pancreas}} | |||
{{Colon}} | |||
{{Lung}} | |||
{{Trachea}} | |||
{{Bronchi}} | |||
{{Pleura}} | |||
{{Mediastinum}} | |||
{{Thyroid gland}} | |||
{{Parathyroid}} | |||
{{Adrenal glands}} | |||
{{Pituitary gland}} | |||
{{Pancreas}} | |||
{{Thymus gland}} | |||
Revision as of 21:19, 9 September 2024
Go back to European Union page
Primary purpose: To advocate globally for patients with neuroendocrine cancer and genetic neuroendocrine tumours (NETs) by raising awareness, promoting scientific advancements, and fostering collaboration to ensure timely diagnosis, optimal treatment, support, and care.
Cancer areas of interest: C15-C26: Digestive system cancers, C30-C39: Lung/chest cancers and C73-C75: Thyroid and other gland cancers.
Access to information: Click here to access.
